nodes	percent_of_prediction	percent_of_DWPC	metapath
Amifostine—ALPPL2—prostate cancer	0.414	0.569	CbGaD
Amifostine—ALPL—prostate cancer	0.314	0.431	CbGaD
Amifostine—ALPPL2—urine—prostate cancer	0.0174	0.288	CbGeAlD
Amifostine—ALPL—prostate gland—prostate cancer	0.00707	0.117	CbGeAlD
Amifostine—ENPP1—prostate gland—prostate cancer	0.00649	0.107	CbGeAlD
Amifostine—ALPPL2—epithelium—prostate cancer	0.0046	0.0759	CbGeAlD
Amifostine—ENPP1—renal system—prostate cancer	0.00442	0.0731	CbGeAlD
Amifostine—ALPPL2—renal system—prostate cancer	0.00426	0.0704	CbGeAlD
Amifostine—ALPPL2—bone marrow—prostate cancer	0.00322	0.0532	CbGeAlD
Amifostine—ALPL—testis—prostate cancer	0.00311	0.0514	CbGeAlD
Amifostine—ENPP1—testis—prostate cancer	0.00286	0.0472	CbGeAlD
Amifostine—ALPPL2—testis—prostate cancer	0.00275	0.0455	CbGeAlD
Amifostine—ALPL—lymph node—prostate cancer	0.00226	0.0373	CbGeAlD
Amifostine—ENPP1—lymph node—prostate cancer	0.00207	0.0342	CbGeAlD
Amifostine—ALPL—Endochondral Ossification—PTHLH—prostate cancer	0.00107	0.0113	CbGpPWpGaD
Amifostine—ENPP1—Endochondral Ossification—ALPL—prostate cancer	0.00104	0.0109	CbGpPWpGaD
Amifostine—ALPL—AGE/RAGE pathway—PRKCZ—prostate cancer	0.000963	0.0102	CbGpPWpGaD
Amifostine—ENPP1—Insulin Signaling—STX4—prostate cancer	0.000962	0.0102	CbGpPWpGaD
Amifostine—ENPP1—Endochondral Ossification—MMP13—prostate cancer	0.000942	0.00994	CbGpPWpGaD
Amifostine—ENPP1—Defective AMN causes hereditary megaloblastic anemia 1—GSTO1—prostate cancer	0.000939	0.00991	CbGpPWpGaD
Amifostine—ENPP1—Betamethasone—Prednisone—prostate cancer	0.000934	0.5	CbGdCrCtD
Amifostine—ENPP1—Dexamethasone—Prednisone—prostate cancer	0.000934	0.5	CbGdCrCtD
Amifostine—ENPP1—Endochondral Ossification—PTHLH—prostate cancer	0.000909	0.0096	CbGpPWpGaD
Amifostine—ALPL—NOTCH1 regulation of human endothelial cell calcification—VEGFA—prostate cancer	0.000894	0.00944	CbGpPWpGaD
Amifostine—ALPL—AGE/RAGE pathway—CASP9—prostate cancer	0.000845	0.00892	CbGpPWpGaD
Amifostine—ALPL—Endochondral Ossification—IGF1R—prostate cancer	0.000714	0.00753	CbGpPWpGaD
Amifostine—ENPP1—Endochondral Ossification—IGF1R—prostate cancer	0.000607	0.00641	CbGpPWpGaD
Amifostine—ALPL—Endochondral Ossification—PLAU—prostate cancer	0.000582	0.00614	CbGpPWpGaD
Amifostine—ALPL—AGE/RAGE pathway—HIF1A—prostate cancer	0.000573	0.00605	CbGpPWpGaD
Amifostine—ALPL—AGE/RAGE pathway—IRS1—prostate cancer	0.000499	0.00527	CbGpPWpGaD
Amifostine—ENPP1—Endochondral Ossification—PLAU—prostate cancer	0.000495	0.00522	CbGpPWpGaD
Amifostine—ALPL—AGE/RAGE pathway—INS—prostate cancer	0.000478	0.00505	CbGpPWpGaD
Amifostine—ALPL—Endochondral Ossification—IGF1—prostate cancer	0.000474	0.005	CbGpPWpGaD
Amifostine—ALPL—AGE/RAGE pathway—MMP2—prostate cancer	0.000447	0.00472	CbGpPWpGaD
Amifostine—ALPL—AGE/RAGE pathway—MAP2K1—prostate cancer	0.000447	0.00472	CbGpPWpGaD
Amifostine—ALPL—BDNF signaling pathway—EGR1—prostate cancer	0.000441	0.00466	CbGpPWpGaD
Amifostine—ALPL—BDNF signaling pathway—NGFR—prostate cancer	0.000439	0.00463	CbGpPWpGaD
Amifostine—ALPL—Endochondral Ossification—FGF2—prostate cancer	0.000436	0.0046	CbGpPWpGaD
Amifostine—ALPL—AGE/RAGE pathway—NOS3—prostate cancer	0.000419	0.00443	CbGpPWpGaD
Amifostine—ENPP1—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—prostate cancer	0.00041	0.00433	CbGpPWpGaD
Amifostine—ALPL—AGE/RAGE pathway—JAK2—prostate cancer	0.000407	0.0043	CbGpPWpGaD
Amifostine—ENPP1—Insulin Signaling—PRKCZ—prostate cancer	0.000403	0.00426	CbGpPWpGaD
Amifostine—ENPP1—Endochondral Ossification—IGF1—prostate cancer	0.000403	0.00425	CbGpPWpGaD
Amifostine—ALPL—BDNF signaling pathway—VAV3—prostate cancer	0.000402	0.00425	CbGpPWpGaD
Amifostine—ENPP1—Endochondral Ossification—FGF2—prostate cancer	0.00037	0.00391	CbGpPWpGaD
Amifostine—ALPL—AGE/RAGE pathway—CASP3—prostate cancer	0.000356	0.00376	CbGpPWpGaD
Amifostine—ENPP1—Insulin Signaling—EGR1—prostate cancer	0.000345	0.00364	CbGpPWpGaD
Amifostine—ALPL—Endochondral Ossification—MMP9—prostate cancer	0.000345	0.00364	CbGpPWpGaD
Amifostine—ENPP1—Insulin Signaling—PRKCQ—prostate cancer	0.000343	0.00362	CbGpPWpGaD
Amifostine—ENPP1—Insulin Signaling—MAP3K7—prostate cancer	0.000339	0.00358	CbGpPWpGaD
Amifostine—ALPL—AGE/RAGE pathway—MMP9—prostate cancer	0.000336	0.00355	CbGpPWpGaD
Amifostine—ALPL—AGE/RAGE pathway—SRC—prostate cancer	0.00031	0.00327	CbGpPWpGaD
Amifostine—ALPL—Endochondral Ossification—VEGFA—prostate cancer	0.00031	0.00327	CbGpPWpGaD
Amifostine—ALPL—AGE/RAGE pathway—STAT3—prostate cancer	0.000299	0.00316	CbGpPWpGaD
Amifostine—ENPP1—Endochondral Ossification—MMP9—prostate cancer	0.000293	0.00309	CbGpPWpGaD
Amifostine—ENPP1—Insulin Signaling—IGF1R—prostate cancer	0.000292	0.00308	CbGpPWpGaD
Amifostine—ALPL—Endochondral Ossification—TGFB1—prostate cancer	0.000284	0.003	CbGpPWpGaD
Amifostine—ALPL—BDNF signaling pathway—BAD—prostate cancer	0.000279	0.00295	CbGpPWpGaD
Amifostine—ALPL—AGE/RAGE pathway—EGFR—prostate cancer	0.000272	0.00287	CbGpPWpGaD
Amifostine—ALPL—BDNF signaling pathway—APC—prostate cancer	0.000271	0.00286	CbGpPWpGaD
Amifostine—ALPL—BDNF signaling pathway—IRS1—prostate cancer	0.000267	0.00282	CbGpPWpGaD
Amifostine—ENPP1—Endochondral Ossification—VEGFA—prostate cancer	0.000263	0.00278	CbGpPWpGaD
Amifostine—ENPP1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—prostate cancer	0.000261	0.00276	CbGpPWpGaD
Amifostine—ALPL—BDNF signaling pathway—GSK3B—prostate cancer	0.00026	0.00274	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—HAO1—prostate cancer	0.000251	0.00265	CbGpPWpGaD
Amifostine—ENPP1—Endochondral Ossification—TGFB1—prostate cancer	0.000242	0.00255	CbGpPWpGaD
Amifostine—ALPL—BDNF signaling pathway—MAP2K1—prostate cancer	0.000239	0.00253	CbGpPWpGaD
Amifostine—ENPP1—Disease—SV2B—prostate cancer	0.000228	0.0024	CbGpPWpGaD
Amifostine—ALPL—BDNF signaling pathway—JAK2—prostate cancer	0.000218	0.0023	CbGpPWpGaD
Amifostine—ENPP1—Disease—AOX1—prostate cancer	0.000214	0.00226	CbGpPWpGaD
Amifostine—ENPP1—Disease—RFK—prostate cancer	0.000214	0.00226	CbGpPWpGaD
Amifostine—ENPP1—Disease—NAGLU—prostate cancer	0.000214	0.00226	CbGpPWpGaD
Amifostine—ENPP1—Disease—PGAM2—prostate cancer	0.000214	0.00226	CbGpPWpGaD
Amifostine—ENPP1—Insulin Signaling—PIK3CG—prostate cancer	0.000211	0.00223	CbGpPWpGaD
Amifostine—ENPP1—Insulin Signaling—IRS1—prostate cancer	0.000209	0.00221	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—ADI1—prostate cancer	0.000205	0.00216	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—PSAT1—prostate cancer	0.000205	0.00216	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—CSAD—prostate cancer	0.000205	0.00216	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—TST—prostate cancer	0.000205	0.00216	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—CBR1—prostate cancer	0.000205	0.00216	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—GRHL1—prostate cancer	0.000205	0.00216	CbGpPWpGaD
Amifostine—ENPP1—Insulin Signaling—GSK3B—prostate cancer	0.000203	0.00214	CbGpPWpGaD
Amifostine—ALPL—Endochondral Ossification—AKT1—prostate cancer	0.000198	0.00209	CbGpPWpGaD
Amifostine—ENPP1—Disease—DNAJC3—prostate cancer	0.000193	0.00204	CbGpPWpGaD
Amifostine—ENPP1—Disease—HSD17B1—prostate cancer	0.000193	0.00204	CbGpPWpGaD
Amifostine—ENPP1—Disease—CTBP2—prostate cancer	0.000193	0.00204	CbGpPWpGaD
Amifostine—ALPL—AGE/RAGE pathway—AKT1—prostate cancer	0.000193	0.00203	CbGpPWpGaD
Amifostine—ALPL—BDNF signaling pathway—CASP3—prostate cancer	0.000191	0.00201	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—CKMT2—prostate cancer	0.000191	0.00201	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—GRHPR—prostate cancer	0.000191	0.00201	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—UGT2B15—prostate cancer	0.000191	0.00201	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—UGT2B17—prostate cancer	0.000191	0.00201	CbGpPWpGaD
Amifostine—ENPP1—Insulin Signaling—MAP2K1—prostate cancer	0.000187	0.00198	CbGpPWpGaD
Amifostine—ENPP1—Insulin Signaling—PIK3CD—prostate cancer	0.000186	0.00196	CbGpPWpGaD
Amifostine—ALPL—BDNF signaling pathway—CTNNB1—prostate cancer	0.000184	0.00194	CbGpPWpGaD
Amifostine—Dyspnoea—Goserelin—prostate cancer	0.000181	0.00158	CcSEcCtD
Amifostine—Somnolence—Goserelin—prostate cancer	0.00018	0.00157	CcSEcCtD
Amifostine—ENPP1—Metabolism—RFK—prostate cancer	0.000179	0.00189	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—MBTPS1—prostate cancer	0.000179	0.00189	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—SULT2B1—prostate cancer	0.000179	0.00189	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—NAGLU—prostate cancer	0.000179	0.00189	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—PGAM2—prostate cancer	0.000179	0.00189	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—AOX1—prostate cancer	0.000179	0.00189	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—GSTM3—prostate cancer	0.000179	0.00189	CbGpPWpGaD
Amifostine—Dyspnoea—Conjugated Estrogens—prostate cancer	0.000179	0.00156	CcSEcCtD
Amifostine—Somnolence—Conjugated Estrogens—prostate cancer	0.000178	0.00156	CcSEcCtD
Amifostine—Malaise—Estradiol—prostate cancer	0.000177	0.00155	CcSEcCtD
Amifostine—Syncope—Estradiol—prostate cancer	0.000176	0.00154	CcSEcCtD
Amifostine—Pruritus—Ethinyl Estradiol—prostate cancer	0.000174	0.00152	CcSEcCtD
Amifostine—Nausea—Bicalutamide—prostate cancer	0.000173	0.00151	CcSEcCtD
Amifostine—Loss of consciousness—Estradiol—prostate cancer	0.000173	0.00151	CcSEcCtD
Amifostine—Cardiac arrest—Prednisone—prostate cancer	0.000173	0.00151	CcSEcCtD
Amifostine—ENPP1—Disease—B4GALT4—prostate cancer	0.000172	0.00182	CbGpPWpGaD
Amifostine—ENPP1—Disease—IL17RD—prostate cancer	0.000172	0.00182	CbGpPWpGaD
Amifostine—Ill-defined disorder—Mitoxantrone—prostate cancer	0.00017	0.00149	CcSEcCtD
Amifostine—Hypertension—Estradiol—prostate cancer	0.00017	0.00148	CcSEcCtD
Amifostine—ENPP1—Metabolism—CYP3A43—prostate cancer	0.00017	0.00179	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—AMACR—prostate cancer	0.00017	0.00179	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—DEGS1—prostate cancer	0.00017	0.00179	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—SRD5A2—prostate cancer	0.00017	0.00179	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—NAT1—prostate cancer	0.00017	0.00179	CbGpPWpGaD
Amifostine—ENPP1—Endochondral Ossification—AKT1—prostate cancer	0.000168	0.00177	CbGpPWpGaD
Amifostine—Chest pain—Estradiol—prostate cancer	0.000168	0.00146	CcSEcCtD
Amifostine—Feeling abnormal—Goserelin—prostate cancer	0.000167	0.00146	CcSEcCtD
Amifostine—ALPL—BDNF signaling pathway—SRC—prostate cancer	0.000166	0.00175	CbGpPWpGaD
Amifostine—Erythema multiforme—Etoposide—prostate cancer	0.000166	0.00145	CcSEcCtD
Amifostine—Discomfort—Estradiol—prostate cancer	0.000166	0.00145	CcSEcCtD
Amifostine—Malaise—Mitoxantrone—prostate cancer	0.000165	0.00144	CcSEcCtD
Amifostine—Dizziness—Ethinyl Estradiol—prostate cancer	0.000163	0.00142	CcSEcCtD
Amifostine—Flushing—Etoposide—prostate cancer	0.000163	0.00142	CcSEcCtD
Amifostine—ENPP1—Metabolism—HSD17B1—prostate cancer	0.000162	0.00171	CbGpPWpGaD
Amifostine—ENPP1—Insulin Signaling—PIK3CB—prostate cancer	0.000162	0.00171	CbGpPWpGaD
Amifostine—Urticaria—Goserelin—prostate cancer	0.000161	0.00141	CcSEcCtD
Amifostine—Stevens-Johnson syndrome—Docetaxel—prostate cancer	0.000161	0.0014	CcSEcCtD
Amifostine—Anaphylactic shock—Estradiol—prostate cancer	0.000161	0.0014	CcSEcCtD
Amifostine—ALPL—BDNF signaling pathway—STAT3—prostate cancer	0.00016	0.00169	CbGpPWpGaD
Amifostine—Body temperature increased—Goserelin—prostate cancer	0.00016	0.0014	CcSEcCtD
Amifostine—Acute coronary syndrome—Docetaxel—prostate cancer	0.00016	0.0014	CcSEcCtD
Amifostine—Renal failure—Docetaxel—prostate cancer	0.000159	0.00139	CcSEcCtD
Amifostine—Urticaria—Conjugated Estrogens—prostate cancer	0.000159	0.00139	CcSEcCtD
Amifostine—Myocardial infarction—Docetaxel—prostate cancer	0.000159	0.00139	CcSEcCtD
Amifostine—Convulsion—Mitoxantrone—prostate cancer	0.000159	0.00139	CcSEcCtD
Amifostine—Body temperature increased—Conjugated Estrogens—prostate cancer	0.000159	0.00139	CcSEcCtD
Amifostine—Hypertension—Mitoxantrone—prostate cancer	0.000158	0.00138	CcSEcCtD
Amifostine—Shock—Estradiol—prostate cancer	0.000158	0.00138	CcSEcCtD
Amifostine—Chills—Etoposide—prostate cancer	0.000157	0.00137	CcSEcCtD
Amifostine—Tachycardia—Estradiol—prostate cancer	0.000157	0.00137	CcSEcCtD
Amifostine—Vomiting—Ethinyl Estradiol—prostate cancer	0.000157	0.00137	CcSEcCtD
Amifostine—Chest pain—Mitoxantrone—prostate cancer	0.000156	0.00136	CcSEcCtD
Amifostine—Stevens-Johnson syndrome—Capecitabine—prostate cancer	0.000156	0.00136	CcSEcCtD
Amifostine—Rash—Ethinyl Estradiol—prostate cancer	0.000155	0.00136	CcSEcCtD
Amifostine—Dermatitis—Ethinyl Estradiol—prostate cancer	0.000155	0.00135	CcSEcCtD
Amifostine—Acute coronary syndrome—Capecitabine—prostate cancer	0.000155	0.00135	CcSEcCtD
Amifostine—Renal failure—Capecitabine—prostate cancer	0.000154	0.00135	CcSEcCtD
Amifostine—Discomfort—Mitoxantrone—prostate cancer	0.000154	0.00135	CcSEcCtD
Amifostine—Myocardial infarction—Capecitabine—prostate cancer	0.000154	0.00134	CcSEcCtD
Amifostine—ENPP1—Disease—WNT4—prostate cancer	0.000154	0.00162	CbGpPWpGaD
Amifostine—Dermatitis exfoliative—Epirubicin—prostate cancer	0.00015	0.00131	CcSEcCtD
Amifostine—Anaphylactic shock—Mitoxantrone—prostate cancer	0.00015	0.00131	CcSEcCtD
Amifostine—Hypersensitivity—Goserelin—prostate cancer	0.000149	0.0013	CcSEcCtD
Amifostine—Hypersensitivity—Conjugated Estrogens—prostate cancer	0.000148	0.00129	CcSEcCtD
Amifostine—Shock—Mitoxantrone—prostate cancer	0.000147	0.00129	CcSEcCtD
Amifostine—Anaphylactoid reaction—Epirubicin—prostate cancer	0.000147	0.00128	CcSEcCtD
Amifostine—Nausea—Ethinyl Estradiol—prostate cancer	0.000146	0.00128	CcSEcCtD
Amifostine—Tachycardia—Mitoxantrone—prostate cancer	0.000146	0.00128	CcSEcCtD
Amifostine—ENPP1—Metabolism—HPGD—prostate cancer	0.000144	0.00152	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—B4GALT4—prostate cancer	0.000144	0.00152	CbGpPWpGaD
Amifostine—Bradycardia—Capecitabine—prostate cancer	0.000144	0.00125	CcSEcCtD
Amifostine—Pruritus—Goserelin—prostate cancer	0.000143	0.00125	CcSEcCtD
Amifostine—Dyspnoea—Estradiol—prostate cancer	0.000143	0.00125	CcSEcCtD
Amifostine—Somnolence—Estradiol—prostate cancer	0.000143	0.00125	CcSEcCtD
Amifostine—Pruritus—Conjugated Estrogens—prostate cancer	0.000142	0.00124	CcSEcCtD
Amifostine—Ill-defined disorder—Etoposide—prostate cancer	0.000142	0.00124	CcSEcCtD
Amifostine—ENPP1—Insulin Signaling—PTEN—prostate cancer	0.00014	0.00148	CbGpPWpGaD
Amifostine—Hypotension—Mitoxantrone—prostate cancer	0.00014	0.00122	CcSEcCtD
Amifostine—Dermatitis exfoliative—Doxorubicin—prostate cancer	0.000139	0.00122	CcSEcCtD
Amifostine—Acute coronary syndrome—Prednisone—prostate cancer	0.000138	0.0012	CcSEcCtD
Amifostine—ENPP1—Disease—RPL12—prostate cancer	0.000138	0.00146	CbGpPWpGaD
Amifostine—ENPP1—Disease—LDHB—prostate cancer	0.000138	0.00146	CbGpPWpGaD
Amifostine—Erythema multiforme—Docetaxel—prostate cancer	0.000138	0.0012	CcSEcCtD
Amifostine—Malaise—Etoposide—prostate cancer	0.000138	0.0012	CcSEcCtD
Amifostine—Myocardial infarction—Prednisone—prostate cancer	0.000137	0.0012	CcSEcCtD
Amifostine—ENPP1—Metabolism—TNFRSF21—prostate cancer	0.000136	0.00143	CbGpPWpGaD
Amifostine—Anaphylactoid reaction—Doxorubicin—prostate cancer	0.000136	0.00119	CcSEcCtD
Amifostine—Flushing—Docetaxel—prostate cancer	0.000135	0.00118	CcSEcCtD
Amifostine—Cardiac arrest—Epirubicin—prostate cancer	0.000135	0.00118	CcSEcCtD
Amifostine—Loss of consciousness—Etoposide—prostate cancer	0.000134	0.00117	CcSEcCtD
Amifostine—Dizziness—Goserelin—prostate cancer	0.000134	0.00117	CcSEcCtD
Amifostine—Dyspnoea—Mitoxantrone—prostate cancer	0.000133	0.00117	CcSEcCtD
Amifostine—Erythema multiforme—Capecitabine—prostate cancer	0.000133	0.00116	CcSEcCtD
Amifostine—Somnolence—Mitoxantrone—prostate cancer	0.000133	0.00116	CcSEcCtD
Amifostine—Dizziness—Conjugated Estrogens—prostate cancer	0.000133	0.00116	CcSEcCtD
Amifostine—Feeling abnormal—Estradiol—prostate cancer	0.000132	0.00116	CcSEcCtD
Amifostine—Convulsion—Etoposide—prostate cancer	0.000132	0.00115	CcSEcCtD
Amifostine—ENPP1—Metabolism—MTAP—prostate cancer	0.000132	0.00139	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—CYP7B1—prostate cancer	0.000132	0.00139	CbGpPWpGaD
Amifostine—Hypertension—Etoposide—prostate cancer	0.000132	0.00115	CcSEcCtD
Amifostine—Flushing—Capecitabine—prostate cancer	0.000131	0.00114	CcSEcCtD
Amifostine—ENPP1—Disease—TCN2—prostate cancer	0.000131	0.00138	CbGpPWpGaD
Amifostine—Chills—Docetaxel—prostate cancer	0.000131	0.00114	CcSEcCtD
Amifostine—Arrhythmia—Docetaxel—prostate cancer	0.00013	0.00114	CcSEcCtD
Amifostine—Chest pain—Etoposide—prostate cancer	0.00013	0.00113	CcSEcCtD
Amifostine—Vomiting—Goserelin—prostate cancer	0.000129	0.00113	CcSEcCtD
Amifostine—ENPP1—Metabolism—SULT1E1—prostate cancer	0.000129	0.00136	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—SRD5A1—prostate cancer	0.000129	0.00136	CbGpPWpGaD
Amifostine—Discomfort—Etoposide—prostate cancer	0.000128	0.00112	CcSEcCtD
Amifostine—Toxic epidermal necrolysis—Epirubicin—prostate cancer	0.000128	0.00112	CcSEcCtD
Amifostine—Bradycardia—Prednisone—prostate cancer	0.000128	0.00112	CcSEcCtD
Amifostine—Rash—Goserelin—prostate cancer	0.000128	0.00112	CcSEcCtD
Amifostine—Dermatitis—Goserelin—prostate cancer	0.000128	0.00111	CcSEcCtD
Amifostine—Vomiting—Conjugated Estrogens—prostate cancer	0.000128	0.00111	CcSEcCtD
Amifostine—Urticaria—Estradiol—prostate cancer	0.000128	0.00111	CcSEcCtD
Amifostine—Body temperature increased—Estradiol—prostate cancer	0.000127	0.00111	CcSEcCtD
Amifostine—Rash—Conjugated Estrogens—prostate cancer	0.000127	0.00111	CcSEcCtD
Amifostine—Chills—Capecitabine—prostate cancer	0.000126	0.0011	CcSEcCtD
Amifostine—Dermatitis—Conjugated Estrogens—prostate cancer	0.000126	0.0011	CcSEcCtD
Amifostine—Arrhythmia—Capecitabine—prostate cancer	0.000126	0.0011	CcSEcCtD
Amifostine—Cardiac arrest—Doxorubicin—prostate cancer	0.000125	0.00109	CcSEcCtD
Amifostine—Anaphylactic shock—Etoposide—prostate cancer	0.000124	0.00109	CcSEcCtD
Amifostine—Feeling abnormal—Mitoxantrone—prostate cancer	0.000123	0.00108	CcSEcCtD
Amifostine—ENPP1—Metabolism—ACSL4—prostate cancer	0.000123	0.0013	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—HSD17B3—prostate cancer	0.000123	0.0013	CbGpPWpGaD
Amifostine—Tachycardia—Etoposide—prostate cancer	0.000121	0.00106	CcSEcCtD
Amifostine—Nausea—Goserelin—prostate cancer	0.00012	0.00105	CcSEcCtD
Amifostine—Nausea—Conjugated Estrogens—prostate cancer	0.000119	0.00104	CcSEcCtD
Amifostine—Urticaria—Mitoxantrone—prostate cancer	0.000119	0.00104	CcSEcCtD
Amifostine—Hypersensitivity—Estradiol—prostate cancer	0.000118	0.00103	CcSEcCtD
Amifostine—Body temperature increased—Mitoxantrone—prostate cancer	0.000118	0.00103	CcSEcCtD
Amifostine—Toxic epidermal necrolysis—Doxorubicin—prostate cancer	0.000118	0.00103	CcSEcCtD
Amifostine—ENPP1—Metabolism—UMPS—prostate cancer	0.000118	0.00124	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—ARG2—prostate cancer	0.000118	0.00124	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—PHGDH—prostate cancer	0.000118	0.00124	CbGpPWpGaD
Amifostine—Flushing—Prednisone—prostate cancer	0.000117	0.00102	CcSEcCtD
Amifostine—Hypotension—Etoposide—prostate cancer	0.000116	0.00102	CcSEcCtD
Amifostine—ENPP1—Metabolism—LDHB—prostate cancer	0.000115	0.00122	CbGpPWpGaD
Amifostine—Ill-defined disorder—Capecitabine—prostate cancer	0.000114	0.000995	CcSEcCtD
Amifostine—Syncope—Docetaxel—prostate cancer	0.000114	0.000993	CcSEcCtD
Amifostine—Pruritus—Estradiol—prostate cancer	0.000114	0.000993	CcSEcCtD
Amifostine—ENPP1—Metabolism—CYP3A5—prostate cancer	0.000113	0.0012	CbGpPWpGaD
Amifostine—Arrhythmia—Prednisone—prostate cancer	0.000112	0.00098	CcSEcCtD
Amifostine—Loss of consciousness—Docetaxel—prostate cancer	0.000111	0.000973	CcSEcCtD
Amifostine—ENPP1—Disease—GSTO1—prostate cancer	0.000111	0.00117	CbGpPWpGaD
Amifostine—Dyspnoea—Etoposide—prostate cancer	0.000111	0.000969	CcSEcCtD
Amifostine—Malaise—Capecitabine—prostate cancer	0.000111	0.000967	CcSEcCtD
Amifostine—Somnolence—Etoposide—prostate cancer	0.000111	0.000967	CcSEcCtD
Amifostine—Hypersensitivity—Mitoxantrone—prostate cancer	0.00011	0.000963	CcSEcCtD
Amifostine—Syncope—Capecitabine—prostate cancer	0.00011	0.000961	CcSEcCtD
Amifostine—Convulsion—Docetaxel—prostate cancer	0.00011	0.000959	CcSEcCtD
Amifostine—ENPP1—Metabolism—PDHA1—prostate cancer	0.000109	0.00116	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—TCN2—prostate cancer	0.000109	0.00116	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—GSTA3—prostate cancer	0.000109	0.00116	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—UCP3—prostate cancer	0.000109	0.00116	CbGpPWpGaD
Amifostine—Hypertension—Docetaxel—prostate cancer	0.000109	0.000956	CcSEcCtD
Amifostine—Stevens-Johnson syndrome—Epirubicin—prostate cancer	0.000108	0.000947	CcSEcCtD
Amifostine—Chest pain—Docetaxel—prostate cancer	0.000108	0.000943	CcSEcCtD
Amifostine—Loss of consciousness—Capecitabine—prostate cancer	0.000108	0.000942	CcSEcCtD
Amifostine—Renal failure—Epirubicin—prostate cancer	0.000108	0.000939	CcSEcCtD
Amifostine—ENPP1—Disease—LRP2—prostate cancer	0.000107	0.00112	CbGpPWpGaD
Amifostine—Dizziness—Estradiol—prostate cancer	0.000106	0.000928	CcSEcCtD
Amifostine—Hypertension—Capecitabine—prostate cancer	0.000106	0.000926	CcSEcCtD
Amifostine—Chest pain—Capecitabine—prostate cancer	0.000104	0.000913	CcSEcCtD
Amifostine—ENPP1—Disease—P4HB—prostate cancer	0.000104	0.0011	CbGpPWpGaD
Amifostine—ENPP1—Disease—RPL10—prostate cancer	0.000104	0.0011	CbGpPWpGaD
Amifostine—ENPP1—Disease—EIF2AK2—prostate cancer	0.000104	0.0011	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—HSD3B1—prostate cancer	0.000104	0.0011	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—SLC22A3—prostate cancer	0.000104	0.0011	CbGpPWpGaD
Amifostine—Anaphylactic shock—Docetaxel—prostate cancer	0.000103	0.000904	CcSEcCtD
Amifostine—ALPL—BDNF signaling pathway—AKT1—prostate cancer	0.000103	0.00109	CbGpPWpGaD
Amifostine—Discomfort—Capecitabine—prostate cancer	0.000103	0.000902	CcSEcCtD
Amifostine—Feeling abnormal—Etoposide—prostate cancer	0.000103	0.000896	CcSEcCtD
Amifostine—ENPP1—Disease—HIST1H2BG—prostate cancer	0.000103	0.00108	CbGpPWpGaD
Amifostine—Vomiting—Estradiol—prostate cancer	0.000102	0.000892	CcSEcCtD
Amifostine—Shock—Docetaxel—prostate cancer	0.000102	0.000889	CcSEcCtD
Amifostine—Ill-defined disorder—Prednisone—prostate cancer	0.000101	0.000886	CcSEcCtD
Amifostine—Rash—Estradiol—prostate cancer	0.000101	0.000885	CcSEcCtD
Amifostine—Dermatitis—Estradiol—prostate cancer	0.000101	0.000884	CcSEcCtD
Amifostine—Tachycardia—Docetaxel—prostate cancer	0.000101	0.000882	CcSEcCtD
Amifostine—Stevens-Johnson syndrome—Doxorubicin—prostate cancer	0.0001	0.000877	CcSEcCtD
Amifostine—ENPP1—Metabolism—TBXAS1—prostate cancer	0.0001	0.00106	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—GSTA4—prostate cancer	0.0001	0.00106	CbGpPWpGaD
Amifostine—Bradycardia—Epirubicin—prostate cancer	0.0001	0.000873	CcSEcCtD
Amifostine—Renal failure—Doxorubicin—prostate cancer	9.95e-05	0.000869	CcSEcCtD
Amifostine—ENPP1—Disease—NPPA—prostate cancer	9.9e-05	0.00105	CbGpPWpGaD
Amifostine—ENPP1—Disease—HIST1H4H—prostate cancer	9.9e-05	0.00105	CbGpPWpGaD
Amifostine—Urticaria—Etoposide—prostate cancer	9.89e-05	0.000864	CcSEcCtD
Amifostine—ENPP1—Insulin Signaling—PIK3CA—prostate cancer	9.88e-05	0.00104	CbGpPWpGaD
Amifostine—Malaise—Prednisone—prostate cancer	9.86e-05	0.000861	CcSEcCtD
Amifostine—Shock—Capecitabine—prostate cancer	9.85e-05	0.000861	CcSEcCtD
Amifostine—Body temperature increased—Etoposide—prostate cancer	9.84e-05	0.00086	CcSEcCtD
Amifostine—Syncope—Prednisone—prostate cancer	9.8e-05	0.000856	CcSEcCtD
Amifostine—Tachycardia—Capecitabine—prostate cancer	9.78e-05	0.000854	CcSEcCtD
Amifostine—ENPP1—Metabolism—GSTA2—prostate cancer	9.75e-05	0.00103	CbGpPWpGaD
Amifostine—Hypotension—Docetaxel—prostate cancer	9.67e-05	0.000844	CcSEcCtD
Amifostine—ENPP1—Metabolism—ABCG5—prostate cancer	9.64e-05	0.00102	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—SULT1A1—prostate cancer	9.64e-05	0.00102	CbGpPWpGaD
Amifostine—Loss of consciousness—Prednisone—prostate cancer	9.61e-05	0.000839	CcSEcCtD
Amifostine—Nausea—Estradiol—prostate cancer	9.54e-05	0.000833	CcSEcCtD
Amifostine—Vomiting—Mitoxantrone—prostate cancer	9.52e-05	0.000831	CcSEcCtD
Amifostine—Convulsion—Prednisone—prostate cancer	9.47e-05	0.000827	CcSEcCtD
Amifostine—Hypertension—Prednisone—prostate cancer	9.44e-05	0.000824	CcSEcCtD
Amifostine—Rash—Mitoxantrone—prostate cancer	9.44e-05	0.000824	CcSEcCtD
Amifostine—Dermatitis—Mitoxantrone—prostate cancer	9.43e-05	0.000823	CcSEcCtD
Amifostine—ENPP1—Metabolism—GSTA1—prostate cancer	9.41e-05	0.000994	CbGpPWpGaD
Amifostine—Hypotension—Capecitabine—prostate cancer	9.36e-05	0.000818	CcSEcCtD
Amifostine—ENPP1—Metabolism—GSTO1—prostate cancer	9.31e-05	0.000982	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—HSD3B2—prostate cancer	9.31e-05	0.000982	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—NAT2—prostate cancer	9.31e-05	0.000982	CbGpPWpGaD
Amifostine—Erythema multiforme—Epirubicin—prostate cancer	9.29e-05	0.000811	CcSEcCtD
Amifostine—Bradycardia—Doxorubicin—prostate cancer	9.25e-05	0.000808	CcSEcCtD
Amifostine—Dyspnoea—Docetaxel—prostate cancer	9.22e-05	0.000806	CcSEcCtD
Amifostine—Somnolence—Docetaxel—prostate cancer	9.2e-05	0.000803	CcSEcCtD
Amifostine—Discomfort—Prednisone—prostate cancer	9.2e-05	0.000803	CcSEcCtD
Amifostine—Hypersensitivity—Etoposide—prostate cancer	9.17e-05	0.000801	CcSEcCtD
Amifostine—Flushing—Epirubicin—prostate cancer	9.12e-05	0.000796	CcSEcCtD
Amifostine—Dyspnoea—Capecitabine—prostate cancer	8.93e-05	0.00078	CcSEcCtD
Amifostine—ENPP1—Metabolism—CYP2C18—prostate cancer	8.92e-05	0.000942	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—LRP2—prostate cancer	8.92e-05	0.000942	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—PLCB2—prostate cancer	8.92e-05	0.000942	CbGpPWpGaD
Amifostine—Anaphylactic shock—Prednisone—prostate cancer	8.92e-05	0.000779	CcSEcCtD
Amifostine—Nausea—Mitoxantrone—prostate cancer	8.89e-05	0.000776	CcSEcCtD
Amifostine—Chills—Epirubicin—prostate cancer	8.81e-05	0.00077	CcSEcCtD
Amifostine—Pruritus—Etoposide—prostate cancer	8.81e-05	0.000769	CcSEcCtD
Amifostine—Shock—Prednisone—prostate cancer	8.78e-05	0.000767	CcSEcCtD
Amifostine—Arrhythmia—Epirubicin—prostate cancer	8.77e-05	0.000766	CcSEcCtD
Amifostine—ENPP1—Metabolism—P4HB—prostate cancer	8.75e-05	0.000924	CbGpPWpGaD
Amifostine—Tachycardia—Prednisone—prostate cancer	8.71e-05	0.000761	CcSEcCtD
Amifostine—Erythema multiforme—Doxorubicin—prostate cancer	8.59e-05	0.000751	CcSEcCtD
Amifostine—Feeling abnormal—Docetaxel—prostate cancer	8.52e-05	0.000745	CcSEcCtD
Amifostine—ENPP1—Metabolism—SLC22A1—prostate cancer	8.51e-05	0.000899	CbGpPWpGaD
Amifostine—Flushing—Doxorubicin—prostate cancer	8.43e-05	0.000737	CcSEcCtD
Amifostine—ENPP1—Disease—TGFBR1—prostate cancer	8.42e-05	0.000889	CbGpPWpGaD
Amifostine—ENPP1—Disease—B2M—prostate cancer	8.42e-05	0.000889	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—SULT2A1—prostate cancer	8.29e-05	0.000876	CbGpPWpGaD
Amifostine—ENPP1—Disease—AKR1C3—prostate cancer	8.28e-05	0.000875	CbGpPWpGaD
Amifostine—ENPP1—Disease—RPS19—prostate cancer	8.28e-05	0.000875	CbGpPWpGaD
Amifostine—Feeling abnormal—Capecitabine—prostate cancer	8.25e-05	0.000721	CcSEcCtD
Amifostine—ENPP1—Disease—PRKACB—prostate cancer	8.24e-05	0.00087	CbGpPWpGaD
Amifostine—Dizziness—Etoposide—prostate cancer	8.23e-05	0.000719	CcSEcCtD
Amifostine—Body temperature increased—Docetaxel—prostate cancer	8.18e-05	0.000714	CcSEcCtD
Amifostine—ENPP1—Metabolism—MED12—prostate cancer	8.16e-05	0.000861	CbGpPWpGaD
Amifostine—Chills—Doxorubicin—prostate cancer	8.15e-05	0.000712	CcSEcCtD
Amifostine—Arrhythmia—Doxorubicin—prostate cancer	8.12e-05	0.000709	CcSEcCtD
Amifostine—ENPP1—Metabolism—GNG5—prostate cancer	8.1e-05	0.000855	CbGpPWpGaD
Amifostine—ENPP1—Insulin Signaling—AKT1—prostate cancer	8.07e-05	0.000852	CbGpPWpGaD
Amifostine—ENPP1—Disease—PPP3CA—prostate cancer	8.03e-05	0.000848	CbGpPWpGaD
Amifostine—Urticaria—Capecitabine—prostate cancer	7.96e-05	0.000695	CcSEcCtD
Amifostine—Ill-defined disorder—Epirubicin—prostate cancer	7.93e-05	0.000693	CcSEcCtD
Amifostine—Body temperature increased—Capecitabine—prostate cancer	7.92e-05	0.000692	CcSEcCtD
Amifostine—Vomiting—Etoposide—prostate cancer	7.91e-05	0.000691	CcSEcCtD
Amifostine—Rash—Etoposide—prostate cancer	7.85e-05	0.000686	CcSEcCtD
Amifostine—Dermatitis—Etoposide—prostate cancer	7.84e-05	0.000685	CcSEcCtD
Amifostine—ENPP1—Metabolism—NCOA3—prostate cancer	7.8e-05	0.000823	CbGpPWpGaD
Amifostine—ENPP1—Disease—PRKCZ—prostate cancer	7.77e-05	0.00082	CbGpPWpGaD
Amifostine—Malaise—Epirubicin—prostate cancer	7.71e-05	0.000673	CcSEcCtD
Amifostine—Syncope—Epirubicin—prostate cancer	7.67e-05	0.00067	CcSEcCtD
Amifostine—ENPP1—Disease—CALR—prostate cancer	7.63e-05	0.000806	CbGpPWpGaD
Amifostine—Hypersensitivity—Docetaxel—prostate cancer	7.62e-05	0.000666	CcSEcCtD
Amifostine—Loss of consciousness—Epirubicin—prostate cancer	7.51e-05	0.000656	CcSEcCtD
Amifostine—ENPP1—Disease—FGFR4—prostate cancer	7.51e-05	0.000792	CbGpPWpGaD
Amifostine—ENPP1—Disease—PARP1—prostate cancer	7.51e-05	0.000792	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—HPGDS—prostate cancer	7.44e-05	0.000785	CbGpPWpGaD
Amifostine—ENPP1—Disease—CALCA—prostate cancer	7.41e-05	0.000783	CbGpPWpGaD
Amifostine—Convulsion—Epirubicin—prostate cancer	7.41e-05	0.000647	CcSEcCtD
Amifostine—Nausea—Etoposide—prostate cancer	7.39e-05	0.000646	CcSEcCtD
Amifostine—ENPP1—Metabolism—CYP2C19—prostate cancer	7.39e-05	0.00078	CbGpPWpGaD
Amifostine—Hypertension—Epirubicin—prostate cancer	7.38e-05	0.000645	CcSEcCtD
Amifostine—Hypersensitivity—Capecitabine—prostate cancer	7.38e-05	0.000645	CcSEcCtD
Amifostine—Feeling abnormal—Prednisone—prostate cancer	7.35e-05	0.000642	CcSEcCtD
Amifostine—Ill-defined disorder—Doxorubicin—prostate cancer	7.34e-05	0.000641	CcSEcCtD
Amifostine—Pruritus—Docetaxel—prostate cancer	7.32e-05	0.000639	CcSEcCtD
Amifostine—Chest pain—Epirubicin—prostate cancer	7.28e-05	0.000636	CcSEcCtD
Amifostine—ENPP1—Metabolism—ACHE—prostate cancer	7.22e-05	0.000762	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—GSTT1—prostate cancer	7.22e-05	0.000762	CbGpPWpGaD
Amifostine—Discomfort—Epirubicin—prostate cancer	7.19e-05	0.000628	CcSEcCtD
Amifostine—Malaise—Doxorubicin—prostate cancer	7.13e-05	0.000623	CcSEcCtD
Amifostine—ENPP1—Metabolism—CYP2A6—prostate cancer	7.13e-05	0.000753	CbGpPWpGaD
Amifostine—ENPP1—Disease—HSPA1A—prostate cancer	7.11e-05	0.00075	CbGpPWpGaD
Amifostine—Syncope—Doxorubicin—prostate cancer	7.09e-05	0.00062	CcSEcCtD
Amifostine—Urticaria—Prednisone—prostate cancer	7.09e-05	0.000619	CcSEcCtD
Amifostine—Pruritus—Capecitabine—prostate cancer	7.09e-05	0.000619	CcSEcCtD
Amifostine—Body temperature increased—Prednisone—prostate cancer	7.05e-05	0.000616	CcSEcCtD
Amifostine—Anaphylactic shock—Epirubicin—prostate cancer	6.98e-05	0.000609	CcSEcCtD
Amifostine—Loss of consciousness—Doxorubicin—prostate cancer	6.95e-05	0.000607	CcSEcCtD
Amifostine—ENPP1—Metabolism—AKR1C3—prostate cancer	6.94e-05	0.000732	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—PRKACB—prostate cancer	6.9e-05	0.000729	CbGpPWpGaD
Amifostine—Shock—Epirubicin—prostate cancer	6.86e-05	0.0006	CcSEcCtD
Amifostine—Convulsion—Doxorubicin—prostate cancer	6.85e-05	0.000599	CcSEcCtD
Amifostine—Dizziness—Docetaxel—prostate cancer	6.84e-05	0.000598	CcSEcCtD
Amifostine—ENPP1—Metabolism—CYP17A1—prostate cancer	6.83e-05	0.000721	CbGpPWpGaD
Amifostine—Hypertension—Doxorubicin—prostate cancer	6.83e-05	0.000597	CcSEcCtD
Amifostine—ENPP1—Disease—CASP9—prostate cancer	6.82e-05	0.00072	CbGpPWpGaD
Amifostine—Tachycardia—Epirubicin—prostate cancer	6.81e-05	0.000595	CcSEcCtD
Amifostine—Chest pain—Doxorubicin—prostate cancer	6.73e-05	0.000588	CcSEcCtD
Amifostine—Discomfort—Doxorubicin—prostate cancer	6.65e-05	0.000581	CcSEcCtD
Amifostine—Dizziness—Capecitabine—prostate cancer	6.62e-05	0.000579	CcSEcCtD
Amifostine—ENPP1—Disease—PRKCQ—prostate cancer	6.61e-05	0.000698	CbGpPWpGaD
Amifostine—Vomiting—Docetaxel—prostate cancer	6.58e-05	0.000575	CcSEcCtD
Amifostine—Hypersensitivity—Prednisone—prostate cancer	6.57e-05	0.000574	CcSEcCtD
Amifostine—Rash—Docetaxel—prostate cancer	6.52e-05	0.00057	CcSEcCtD
Amifostine—Hypotension—Epirubicin—prostate cancer	6.52e-05	0.00057	CcSEcCtD
Amifostine—Dermatitis—Docetaxel—prostate cancer	6.52e-05	0.000569	CcSEcCtD
Amifostine—ENPP1—Metabolism—NCOA2—prostate cancer	6.51e-05	0.000687	CbGpPWpGaD
Amifostine—Anaphylactic shock—Doxorubicin—prostate cancer	6.46e-05	0.000564	CcSEcCtD
Amifostine—Vomiting—Capecitabine—prostate cancer	6.37e-05	0.000556	CcSEcCtD
Amifostine—Shock—Doxorubicin—prostate cancer	6.35e-05	0.000555	CcSEcCtD
Amifostine—Rash—Capecitabine—prostate cancer	6.32e-05	0.000552	CcSEcCtD
Amifostine—Pruritus—Prednisone—prostate cancer	6.31e-05	0.000551	CcSEcCtD
Amifostine—Dermatitis—Capecitabine—prostate cancer	6.31e-05	0.000551	CcSEcCtD
Amifostine—Tachycardia—Doxorubicin—prostate cancer	6.3e-05	0.00055	CcSEcCtD
Amifostine—ENPP1—Disease—FGF10—prostate cancer	6.28e-05	0.000663	CbGpPWpGaD
Amifostine—Dyspnoea—Epirubicin—prostate cancer	6.22e-05	0.000543	CcSEcCtD
Amifostine—ENPP1—Metabolism—SLC5A5—prostate cancer	6.21e-05	0.000655	CbGpPWpGaD
Amifostine—Somnolence—Epirubicin—prostate cancer	6.2e-05	0.000542	CcSEcCtD
Amifostine—Nausea—Docetaxel—prostate cancer	6.14e-05	0.000537	CcSEcCtD
Amifostine—ENPP1—Metabolism—CYP2E1—prostate cancer	6.06e-05	0.00064	CbGpPWpGaD
Amifostine—Hypotension—Doxorubicin—prostate cancer	6.03e-05	0.000527	CcSEcCtD
Amifostine—ENPP1—Metabolism—NQO1—prostate cancer	6e-05	0.000633	CbGpPWpGaD
Amifostine—ENPP1—Disease—TGFBR2—prostate cancer	5.97e-05	0.00063	CbGpPWpGaD
Amifostine—Nausea—Capecitabine—prostate cancer	5.95e-05	0.00052	CcSEcCtD
Amifostine—ENPP1—Metabolism—TH—prostate cancer	5.91e-05	0.000624	CbGpPWpGaD
Amifostine—Dizziness—Prednisone—prostate cancer	5.9e-05	0.000515	CcSEcCtD
Amifostine—ENPP1—Disease—ITPR1—prostate cancer	5.88e-05	0.00062	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—CYP3A4—prostate cancer	5.85e-05	0.000617	CbGpPWpGaD
Amifostine—Dyspnoea—Doxorubicin—prostate cancer	5.76e-05	0.000503	CcSEcCtD
Amifostine—Feeling abnormal—Epirubicin—prostate cancer	5.75e-05	0.000502	CcSEcCtD
Amifostine—ENPP1—Metabolism—CYP1B1—prostate cancer	5.75e-05	0.000607	CbGpPWpGaD
Amifostine—Somnolence—Doxorubicin—prostate cancer	5.74e-05	0.000501	CcSEcCtD
Amifostine—Vomiting—Prednisone—prostate cancer	5.67e-05	0.000495	CcSEcCtD
Amifostine—Rash—Prednisone—prostate cancer	5.63e-05	0.000491	CcSEcCtD
Amifostine—Dermatitis—Prednisone—prostate cancer	5.62e-05	0.000491	CcSEcCtD
Amifostine—ENPP1—Metabolism—GGT1—prostate cancer	5.57e-05	0.000588	CbGpPWpGaD
Amifostine—Urticaria—Epirubicin—prostate cancer	5.54e-05	0.000484	CcSEcCtD
Amifostine—Body temperature increased—Epirubicin—prostate cancer	5.52e-05	0.000482	CcSEcCtD
Amifostine—ENPP1—Metabolism—NCOA1—prostate cancer	5.48e-05	0.000579	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—CYP19A1—prostate cancer	5.41e-05	0.000571	CbGpPWpGaD
Amifostine—ENPP1—Disease—LPL—prostate cancer	5.39e-05	0.000569	CbGpPWpGaD
Amifostine—ENPP1—Disease—PDGFRB—prostate cancer	5.34e-05	0.000564	CbGpPWpGaD
Amifostine—Feeling abnormal—Doxorubicin—prostate cancer	5.32e-05	0.000465	CcSEcCtD
Amifostine—Nausea—Prednisone—prostate cancer	5.3e-05	0.000463	CcSEcCtD
Amifostine—ENPP1—Metabolism—RXRA—prostate cancer	5.22e-05	0.000551	CbGpPWpGaD
Amifostine—ENPP1—Disease—ERCC2—prostate cancer	5.16e-05	0.000545	CbGpPWpGaD
Amifostine—Hypersensitivity—Epirubicin—prostate cancer	5.14e-05	0.000449	CcSEcCtD
Amifostine—Urticaria—Doxorubicin—prostate cancer	5.13e-05	0.000448	CcSEcCtD
Amifostine—Body temperature increased—Doxorubicin—prostate cancer	5.1e-05	0.000446	CcSEcCtD
Amifostine—ENPP1—Disease—ERBB3—prostate cancer	5.05e-05	0.000533	CbGpPWpGaD
Amifostine—ENPP1—Disease—FGFR2—prostate cancer	5.04e-05	0.000532	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—COMT—prostate cancer	5.03e-05	0.00053	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—GSTP1—prostate cancer	5e-05	0.000528	CbGpPWpGaD
Amifostine—Pruritus—Epirubicin—prostate cancer	4.94e-05	0.000431	CcSEcCtD
Amifostine—ENPP1—Metabolism—ITPR1—prostate cancer	4.92e-05	0.00052	CbGpPWpGaD
Amifostine—ENPP1—Disease—MTHFR—prostate cancer	4.85e-05	0.000512	CbGpPWpGaD
Amifostine—ENPP1—Disease—TERT—prostate cancer	4.84e-05	0.000511	CbGpPWpGaD
Amifostine—Hypersensitivity—Doxorubicin—prostate cancer	4.76e-05	0.000415	CcSEcCtD
Amifostine—ENPP1—Metabolism—TYMS—prostate cancer	4.65e-05	0.000491	CbGpPWpGaD
Amifostine—ENPP1—Disease—HIF1A—prostate cancer	4.63e-05	0.000488	CbGpPWpGaD
Amifostine—Dizziness—Epirubicin—prostate cancer	4.61e-05	0.000403	CcSEcCtD
Amifostine—ENPP1—Metabolism—GSTM1—prostate cancer	4.6e-05	0.000485	CbGpPWpGaD
Amifostine—Pruritus—Doxorubicin—prostate cancer	4.57e-05	0.000399	CcSEcCtD
Amifostine—ENPP1—Metabolism—LPL—prostate cancer	4.51e-05	0.000476	CbGpPWpGaD
Amifostine—ENPP1—Disease—CAV1—prostate cancer	4.47e-05	0.000472	CbGpPWpGaD
Amifostine—Vomiting—Epirubicin—prostate cancer	4.44e-05	0.000388	CcSEcCtD
Amifostine—Rash—Epirubicin—prostate cancer	4.4e-05	0.000384	CcSEcCtD
Amifostine—Dermatitis—Epirubicin—prostate cancer	4.4e-05	0.000384	CcSEcCtD
Amifostine—ENPP1—Metabolism—CYP1A1—prostate cancer	4.36e-05	0.00046	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—ERCC2—prostate cancer	4.32e-05	0.000456	CbGpPWpGaD
Amifostine—Dizziness—Doxorubicin—prostate cancer	4.27e-05	0.000373	CcSEcCtD
Amifostine—ENPP1—Disease—BAD—prostate cancer	4.21e-05	0.000444	CbGpPWpGaD
Amifostine—Nausea—Epirubicin—prostate cancer	4.14e-05	0.000362	CcSEcCtD
Amifostine—Vomiting—Doxorubicin—prostate cancer	4.11e-05	0.000359	CcSEcCtD
Amifostine—ENPP1—Disease—APC—prostate cancer	4.08e-05	0.00043	CbGpPWpGaD
Amifostine—Rash—Doxorubicin—prostate cancer	4.07e-05	0.000356	CcSEcCtD
Amifostine—Dermatitis—Doxorubicin—prostate cancer	4.07e-05	0.000355	CcSEcCtD
Amifostine—ENPP1—Metabolism—MTHFR—prostate cancer	4.06e-05	0.000429	CbGpPWpGaD
Amifostine—ENPP1—Disease—IRS1—prostate cancer	4.03e-05	0.000425	CbGpPWpGaD
Amifostine—ENPP1—Disease—EGF—prostate cancer	4.03e-05	0.000425	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—PPARA—prostate cancer	3.98e-05	0.000421	CbGpPWpGaD
Amifostine—ENPP1—Disease—GSK3B—prostate cancer	3.91e-05	0.000413	CbGpPWpGaD
Amifostine—ENPP1—Disease—INS—prostate cancer	3.86e-05	0.000407	CbGpPWpGaD
Amifostine—Nausea—Doxorubicin—prostate cancer	3.83e-05	0.000335	CcSEcCtD
Amifostine—ENPP1—Disease—CREBBP—prostate cancer	3.78e-05	0.000399	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—CAV1—prostate cancer	3.75e-05	0.000396	CbGpPWpGaD
Amifostine—ENPP1—Disease—MAP2K1—prostate cancer	3.61e-05	0.000381	CbGpPWpGaD
Amifostine—ENPP1—Disease—PIK3CD—prostate cancer	3.58e-05	0.000378	CbGpPWpGaD
Amifostine—ENPP1—Disease—SERPINE1—prostate cancer	3.54e-05	0.000374	CbGpPWpGaD
Amifostine—ENPP1—Disease—FGF2—prostate cancer	3.43e-05	0.000362	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—PIK3CG—prostate cancer	3.41e-05	0.00036	CbGpPWpGaD
Amifostine—ENPP1—Disease—NOS3—prostate cancer	3.38e-05	0.000357	CbGpPWpGaD
Amifostine—ENPP1—Disease—JAK2—prostate cancer	3.29e-05	0.000347	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—INS—prostate cancer	3.23e-05	0.000341	CbGpPWpGaD
Amifostine—ENPP1—Disease—MDM2—prostate cancer	3.21e-05	0.000339	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—CREBBP—prostate cancer	3.16e-05	0.000334	CbGpPWpGaD
Amifostine—ENPP1—Disease—ERBB2—prostate cancer	3.16e-05	0.000334	CbGpPWpGaD
Amifostine—ENPP1—Disease—PIK3CB—prostate cancer	3.12e-05	0.00033	CbGpPWpGaD
Amifostine—ENPP1—Disease—PTGS2—prostate cancer	3.09e-05	0.000327	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—PIK3CD—prostate cancer	3e-05	0.000317	CbGpPWpGaD
Amifostine—ENPP1—Disease—CDKN1B—prostate cancer	2.93e-05	0.000309	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—NOS3—prostate cancer	2.83e-05	0.000299	CbGpPWpGaD
Amifostine—ENPP1—Disease—CTNNB1—prostate cancer	2.77e-05	0.000292	CbGpPWpGaD
Amifostine—ENPP1—Disease—CDKN1A—prostate cancer	2.7e-05	0.000285	CbGpPWpGaD
Amifostine—ENPP1—Disease—PTEN—prostate cancer	2.7e-05	0.000285	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—PIK3CB—prostate cancer	2.62e-05	0.000276	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—PTGS2—prostate cancer	2.59e-05	0.000274	CbGpPWpGaD
Amifostine—ENPP1—Disease—EP300—prostate cancer	2.57e-05	0.000272	CbGpPWpGaD
Amifostine—ENPP1—Disease—SRC—prostate cancer	2.5e-05	0.000264	CbGpPWpGaD
Amifostine—ENPP1—Disease—STAT3—prostate cancer	2.41e-05	0.000255	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—PTEN—prostate cancer	2.26e-05	0.000239	CbGpPWpGaD
Amifostine—ENPP1—Disease—MYC—prostate cancer	2.24e-05	0.000237	CbGpPWpGaD
Amifostine—ENPP1—Disease—TGFB1—prostate cancer	2.24e-05	0.000236	CbGpPWpGaD
Amifostine—ENPP1—Disease—EGFR—prostate cancer	2.19e-05	0.000232	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—EP300—prostate cancer	2.15e-05	0.000227	CbGpPWpGaD
Amifostine—ENPP1—Disease—KRAS—prostate cancer	2.07e-05	0.000219	CbGpPWpGaD
Amifostine—ENPP1—Disease—PIK3CA—prostate cancer	1.9e-05	0.000201	CbGpPWpGaD
Amifostine—ENPP1—Disease—IL6—prostate cancer	1.69e-05	0.000178	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—PIK3CA—prostate cancer	1.59e-05	0.000168	CbGpPWpGaD
Amifostine—ENPP1—Disease—AKT1—prostate cancer	1.56e-05	0.000164	CbGpPWpGaD
Amifostine—ENPP1—Metabolism—AKT1—prostate cancer	1.3e-05	0.000137	CbGpPWpGaD
